Financhill
Sell
41

TMDX Quote, Financials, Valuation and Earnings

Last price:
$62.37
Seasonality move :
32.05%
Day range:
$59.72 - $62.50
52-week range:
$59.72 - $177.37
Dividend yield:
0%
P/E ratio:
65.68x
P/S ratio:
5.32x
P/B ratio:
9.87x
Volume:
1.6M
Avg. volume:
1.8M
1-year change:
-20.06%
Market cap:
$2.1B
Revenue:
$241.6M
EPS (TTM):
$0.94

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
TMDX
TransMedics Group
$115M $0.32 36.1% 28.58% $102.00
CUTR
Cutera
$32M -$0.96 -28.73% -56.83% --
ELMD
Electromed
$13.5M -- 11.77% -- --
MYO
Myomo
$8.1M -$0.04 108.09% -69.04% $7.04
NARI
Inari Medical
$150.7M -$0.12 21.63% -100% $66.46
STXS
Stereotaxis
$7.1M -$0.05 40.75% -8.33% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
TMDX
TransMedics Group
$61.74 $102.00 $2.1B 65.68x $0.00 0% 5.32x
CUTR
Cutera
$0.36 -- $7.3M -- $0.00 0% 0.05x
ELMD
Electromed
$27.73 -- $234.5M 38.51x $0.00 0% 4.33x
MYO
Myomo
$6.12 $7.04 $185.1M -- $0.00 0% 8.94x
NARI
Inari Medical
$55.48 $66.46 $3.2B -- $0.00 0% 5.60x
STXS
Stereotaxis
$2.35 -- $199.1M -- $0.00 0% 7.87x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
TMDX
TransMedics Group
70.78% 1.280 9.65% 7.00x
CUTR
Cutera
250.93% -2.985 2641.48% 1.68x
ELMD
Electromed
-- 1.671 -- 4.99x
MYO
Myomo
-- 3.291 -- 1.48x
NARI
Inari Medical
-- 1.961 -- 1.32x
STXS
Stereotaxis
-- 2.318 -- 0.90x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
TMDX
TransMedics Group
$60.8M $3.9M 4.86% 19.83% 7.23% -$41.3M
CUTR
Cutera
$1.8M -$36.2M -62.63% -- -109.09% -$24.9M
ELMD
Electromed
$11.5M $1.9M 15.62% 15.62% 13.21% $2.3M
MYO
Myomo
$6.9M -$957.6K -84.04% -84.04% -10.4% -$1.8M
NARI
Inari Medical
$133.5M -$6.7M -17.68% -17.68% -8.21% -$995K
STXS
Stereotaxis
$4.1M -$6.3M -108.68% -108.68% -69% -$4.3M

TransMedics Group vs. Competitors

  • Which has Higher Returns TMDX or CUTR?

    Cutera has a net margin of 3.88% compared to TransMedics Group's net margin of -120.06%. TransMedics Group's return on equity of 19.83% beat Cutera's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    TMDX
    TransMedics Group
    55.94% $0.12 $718.5M
    CUTR
    Cutera
    5.58% -$1.94 $167.5M
  • What do Analysts Say About TMDX or CUTR?

    TransMedics Group has a consensus price target of $102.00, signalling upside risk potential of 65.21%. On the other hand Cutera has an analysts' consensus of -- which suggests that it could grow by 449.9%. Given that Cutera has higher upside potential than TransMedics Group, analysts believe Cutera is more attractive than TransMedics Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    TMDX
    TransMedics Group
    5 3 0
    CUTR
    Cutera
    0 0 0
  • Is TMDX or CUTR More Risky?

    TransMedics Group has a beta of 2.058, which suggesting that the stock is 105.81% more volatile than S&P 500. In comparison Cutera has a beta of 1.263, suggesting its more volatile than the S&P 500 by 26.313%.

  • Which is a Better Dividend Stock TMDX or CUTR?

    TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cutera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Cutera pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios TMDX or CUTR?

    TransMedics Group quarterly revenues are $108.8M, which are larger than Cutera quarterly revenues of $32.5M. TransMedics Group's net income of $4.2M is higher than Cutera's net income of -$39M. Notably, TransMedics Group's price-to-earnings ratio is 65.68x while Cutera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.32x versus 0.05x for Cutera. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMDX
    TransMedics Group
    5.32x 65.68x $108.8M $4.2M
    CUTR
    Cutera
    0.05x -- $32.5M -$39M
  • Which has Higher Returns TMDX or ELMD?

    Electromed has a net margin of 3.88% compared to TransMedics Group's net margin of 10.05%. TransMedics Group's return on equity of 19.83% beat Electromed's return on equity of 15.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMDX
    TransMedics Group
    55.94% $0.12 $718.5M
    ELMD
    Electromed
    78.34% $0.16 $41.5M
  • What do Analysts Say About TMDX or ELMD?

    TransMedics Group has a consensus price target of $102.00, signalling upside risk potential of 65.21%. On the other hand Electromed has an analysts' consensus of -- which suggests that it could grow by 19.01%. Given that TransMedics Group has higher upside potential than Electromed, analysts believe TransMedics Group is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    TMDX
    TransMedics Group
    5 3 0
    ELMD
    Electromed
    0 0 0
  • Is TMDX or ELMD More Risky?

    TransMedics Group has a beta of 2.058, which suggesting that the stock is 105.81% more volatile than S&P 500. In comparison Electromed has a beta of 0.285, suggesting its less volatile than the S&P 500 by 71.506%.

  • Which is a Better Dividend Stock TMDX or ELMD?

    TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios TMDX or ELMD?

    TransMedics Group quarterly revenues are $108.8M, which are larger than Electromed quarterly revenues of $14.7M. TransMedics Group's net income of $4.2M is higher than Electromed's net income of $1.5M. Notably, TransMedics Group's price-to-earnings ratio is 65.68x while Electromed's PE ratio is 38.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.32x versus 4.33x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMDX
    TransMedics Group
    5.32x 65.68x $108.8M $4.2M
    ELMD
    Electromed
    4.33x 38.51x $14.7M $1.5M
  • Which has Higher Returns TMDX or MYO?

    Myomo has a net margin of 3.88% compared to TransMedics Group's net margin of -10.5%. TransMedics Group's return on equity of 19.83% beat Myomo's return on equity of -84.04%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMDX
    TransMedics Group
    55.94% $0.12 $718.5M
    MYO
    Myomo
    75.43% -$0.03 $9.3M
  • What do Analysts Say About TMDX or MYO?

    TransMedics Group has a consensus price target of $102.00, signalling upside risk potential of 65.21%. On the other hand Myomo has an analysts' consensus of $7.04 which suggests that it could grow by 25.27%. Given that TransMedics Group has higher upside potential than Myomo, analysts believe TransMedics Group is more attractive than Myomo.

    Company Buy Ratings Hold Ratings Sell Ratings
    TMDX
    TransMedics Group
    5 3 0
    MYO
    Myomo
    4 0 0
  • Is TMDX or MYO More Risky?

    TransMedics Group has a beta of 2.058, which suggesting that the stock is 105.81% more volatile than S&P 500. In comparison Myomo has a beta of 1.709, suggesting its more volatile than the S&P 500 by 70.858%.

  • Which is a Better Dividend Stock TMDX or MYO?

    TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios TMDX or MYO?

    TransMedics Group quarterly revenues are $108.8M, which are larger than Myomo quarterly revenues of $9.2M. TransMedics Group's net income of $4.2M is higher than Myomo's net income of -$966.4K. Notably, TransMedics Group's price-to-earnings ratio is 65.68x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.32x versus 8.94x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMDX
    TransMedics Group
    5.32x 65.68x $108.8M $4.2M
    MYO
    Myomo
    8.94x -- $9.2M -$966.4K
  • Which has Higher Returns TMDX or NARI?

    Inari Medical has a net margin of 3.88% compared to TransMedics Group's net margin of -11.97%. TransMedics Group's return on equity of 19.83% beat Inari Medical's return on equity of -17.68%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMDX
    TransMedics Group
    55.94% $0.12 $718.5M
    NARI
    Inari Medical
    87.06% -$0.31 $434.8M
  • What do Analysts Say About TMDX or NARI?

    TransMedics Group has a consensus price target of $102.00, signalling upside risk potential of 65.21%. On the other hand Inari Medical has an analysts' consensus of $66.46 which suggests that it could grow by 19.79%. Given that TransMedics Group has higher upside potential than Inari Medical, analysts believe TransMedics Group is more attractive than Inari Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    TMDX
    TransMedics Group
    5 3 0
    NARI
    Inari Medical
    9 5 0
  • Is TMDX or NARI More Risky?

    TransMedics Group has a beta of 2.058, which suggesting that the stock is 105.81% more volatile than S&P 500. In comparison Inari Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock TMDX or NARI?

    TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Inari Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Inari Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios TMDX or NARI?

    TransMedics Group quarterly revenues are $108.8M, which are smaller than Inari Medical quarterly revenues of $153.4M. TransMedics Group's net income of $4.2M is higher than Inari Medical's net income of -$18.4M. Notably, TransMedics Group's price-to-earnings ratio is 65.68x while Inari Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.32x versus 5.60x for Inari Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMDX
    TransMedics Group
    5.32x 65.68x $108.8M $4.2M
    NARI
    Inari Medical
    5.60x -- $153.4M -$18.4M
  • Which has Higher Returns TMDX or STXS?

    Stereotaxis has a net margin of 3.88% compared to TransMedics Group's net margin of -67.31%. TransMedics Group's return on equity of 19.83% beat Stereotaxis's return on equity of -108.68%.

    Company Gross Margin Earnings Per Share Invested Capital
    TMDX
    TransMedics Group
    55.94% $0.12 $718.5M
    STXS
    Stereotaxis
    44.57% -$0.08 $16.2M
  • What do Analysts Say About TMDX or STXS?

    TransMedics Group has a consensus price target of $102.00, signalling upside risk potential of 65.21%. On the other hand Stereotaxis has an analysts' consensus of -- which suggests that it could grow by 91.49%. Given that Stereotaxis has higher upside potential than TransMedics Group, analysts believe Stereotaxis is more attractive than TransMedics Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    TMDX
    TransMedics Group
    5 3 0
    STXS
    Stereotaxis
    0 0 0
  • Is TMDX or STXS More Risky?

    TransMedics Group has a beta of 2.058, which suggesting that the stock is 105.81% more volatile than S&P 500. In comparison Stereotaxis has a beta of 1.570, suggesting its more volatile than the S&P 500 by 57.046%.

  • Which is a Better Dividend Stock TMDX or STXS?

    TransMedics Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios TMDX or STXS?

    TransMedics Group quarterly revenues are $108.8M, which are larger than Stereotaxis quarterly revenues of $9.2M. TransMedics Group's net income of $4.2M is higher than Stereotaxis's net income of -$6.2M. Notably, TransMedics Group's price-to-earnings ratio is 65.68x while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group is 5.32x versus 7.87x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TMDX
    TransMedics Group
    5.32x 65.68x $108.8M $4.2M
    STXS
    Stereotaxis
    7.87x -- $9.2M -$6.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 4.46% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 10.25% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock